KEAP1 and lung adenocarcinoma: Generally, our study comprehensively analyzed the multiplatform data of TCGA to compare the biologic characteristics, intrinsic heterogeneities, and clinical features of the KEAP1/NFE2L2/CUL3 mutant and wild lung adenocarcinoma patients.